IFNγ is secreted by activated immune cells, including Th1-cells, and is highly elevated in the serum and cerebrospinal fluid (CSF) of MS patients, as well as inside MS lesions [21,22]. The gene discussed is IFNG; the disease is myeloid sarcoma.